Abstract: Methods, systems, and devices for accessing a multi-level memory cell are described. The memory device may perform a read operation that includes pre-read portion and a read portion to access the multi-level memory cell. During the pre-read portion, the memory device may apply a plurality of voltages to a plurality of memory cells to identify a likely distribution of memory cells storing a first logic state. During the read portion, the memory device may apply a first read voltage to a memory cell based on performing the pre-read portion. The memory device may apply a second read voltage to the memory cell during the read portion that is based on the first read voltage. The memory device may determine the logic state stored by the memory cell based on applying the first read voltage and the second read voltage.

Abstract: According to embodiments of the present invention, a method of additive manufacturing of an object using object material is provided. The method includes forming the object by processing some of the object material, and forming an object identifier by forming a pattern having at least one coded volume within an internal volume of the object, each of the at least one coded volume enclosing unprocessed object material. According to further embodiments of the present invention, an object manufactured using the method of additive manufacturing and a method of scanning an object identifier formed using the method of additive manufacturing are is also provided.

Abstract: This disclosure relates to a receiver that includes a clock and data recovery loop and a phase offset loop. The clock and data recovery loop may be controlled by a sum of gradients for a plurality of data interleaves. The phase offset loop may be controlled by an accumulated differential gradient for each of the data interleaves.

Abstract: The present invention relates to compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the beta-3 adrenergic receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of a beta-3 adrenergic receptor-mediated disorder, such as, heart failure; cardiac performance in heart failure; mortality, reinfarction, and/or hospitalization in connection with heart failure; acute heart failure; acute decompensated heart failure; congestive heart failure; severe congestive heart failure; organ damage associated with heart failure (e.g.

Abstract: A camera assembly embedded in an electronic device may include a plurality of camera modules, and a supporting frame configured to support the plurality of camera modules. At least one of the plurality of camera modules includes a lens driving assembly configured to move a lens barrel, a lens housing configured to accommodate the lens barrel and the lens driving assembly, a first circuit board on which an image sensor is provided, and a conductive connecting part configured to electrically connect the first circuit board and the lens driving assembly. The supporting frame includes a metal body configured to surround at least portions of edges of the lens housing, and a short-circuit prevention part provided on a surface of the metal body facing the conductive connecting part. The short-circuit prevention part includes a non-conductive material to block electrical contact between the metal body and the conductive connecting part.

Abstract: Pyrazole derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor.

Abstract: One illustrative method disclosed herein includes, among other things, selectively forming a sacrificial material on an upper surface of a top electrode of a memory cell, forming at least one layer of insulating material around the sacrificial material and removing the sacrificial material so as to form an opening in the at least one layer of insulating material, wherein the opening exposes the upper surface of the top electrode. The method also includes forming an internal sidewall spacer within the opening in the at least one layer of insulating material and forming a conductive contact structure that is conductively coupled to the upper surface of the top electrode, wherein a portion of the conductive contact structure is surrounded by the internal sidewall spacer.

Abstract: A camera assembly embedded in an electronic device may include a plurality of camera modules, and a supporting frame configured to support the plurality of camera modules. At least one of the plurality of camera modules includes a lens driving assembly configured to move a lens barrel, a lens housing configured to accommodate the lens barrel and the lens driving assembly, a first circuit board on which an image sensor is provided, and a conductive connecting part configured to electrically connect the first circuit board and the lens driving assembly. The supporting frame includes a metal body configured to surround at least portions of edges of the lens housing, and a short-circuit prevention part provided on a surface of the metal body facing the conductive connecting part. The short-circuit prevention part includes a non-conductive material to block electrical contact between the metal body and the conductive connecting part.

Abstract: This disclosure relates to a receiver comprising a clock and data recovery loop and a phase offset loop. The clock and data recovery loop may be controlled by a sum of gradients for a plurality of data interleaves. The phase offset loop may be controlled by an accumulated differential gradient for each of the data interleaves.

Abstract: This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.

Abstract: A method for producing an ?-olefin oligomer, the method including subjecting ?-olefin to oligomerization reaction to produce an ?-olefin oligomer mixture, carrying out distillation separation of ?-olefin oligomer having less than n carbon atoms in the mixture to obtain a distillation residue containing ?-olefin oligomer having n or more carbon atoms, and then carrying out a step of removing high molecular weight molecules from the distillation residue.

Abstract: One illustrative method disclosed herein includes forming at least one first layer of insulating material above an upper surface of a top electrode of a memory cell, forming a patterned etch stop layer above the at least one first layer of insulating material, wherein the patterned etch stop layer has an opening that is positioned vertically above at least a portion of the upper surface of the top electrode and forming at least one second layer of insulating material above an upper surface of the etch stop layer. The method also includes forming a conductive contact opening that extends through the etch stop layer to expose at least a portion of the upper surface of the top electrode and forming a conductive contact structure in the conductive contact opening, wherein the conductive contact structure is conductively coupled to the upper surface of the top electrode.

Abstract: The present invention relates to compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the beta-3 adrenergic receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of a beta-3 adrenergic receptor-mediated disorder, such as, heart failure; cardiac performance in heart failure; mortality, reinfarction, and/or hospitalization in connection with heart failure; acute heart failure; acute decompensated heart failure; congestive heart failure; severe congestive heart failure; organ damage associated with heart failure (e.g.

Abstract: This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis by administering such modulators and pharmaceutical compositions, and processes for making such modulators.

Abstract: A process for increasing MFR2 of a polyethylene copolymer or an ethylene plastomer or elastomer comprising: (I) extruding a copolymer of polyethylene copolymer having a density of 910 to 970 kg/m3 and an MFR2 of 1 and 100 g/10 min or an ethylene plastomer or elastomer having a density of 855 to 910 kg/m3 and an MFR2 of 0.5 and 100 g/10 min in the presence of 0.1 to 2 wt % of a non-peroxide radical initiator so as to produce a polyethylene copolymer having an MFR2 of 200 g/10 min or more, or an ethylene plastomer or elastomer having a MFR2 of 200 g/10 min or more.

Abstract: One illustrative method disclosed herein includes, among other things, selectively forming a sacrificial material on an upper surface of a top electrode of a memory cell, forming at least one layer of insulating material around the sacrificial material and removing the sacrificial material so as to form an opening in the at least one layer of insulating material, wherein the opening exposes the upper surface of the top electrode. The method also includes forming an internal sidewall spacer within the opening in the at least one layer of insulating material and forming a conductive contact structure that is conductively coupled to the upper surface of the top electrode, wherein a portion of the conductive contact structure is surrounded by the internal sidewall spacer.

Abstract: One illustrative MPT device disclosed herein includes an active region and an inactive region, isolation material positioned between the active region and the inactive region, the isolation material electrically isolating the active region from the inactive region, and an FG MTP cell formed in the active region. In this example, the FG MTP cell includes a floating gate, wherein first, second and third portions of the floating gate are positioned above the active region, the inactive region and the isolation material, respectively, and a control gate positioned above at least a portion of the inactive region, wherein the control gate is positioned above an upper surface and adjacent opposing sidewall surfaces of at least a part of the second portion of the floating gate.

Abstract: The invention proposes a method of calculating aerodynamic derivatives for flight vehicle including the following steps: step 1: simulation and calculation of static aerodynamic coefficients for flight vehicle; step 2: simulate forced harmonic oscillation, specifically: create the harmonic oscillation profile by channels and determine the combined derivative according to the pitch, roll and yaw channels for at least 3 different frequencies; step 3: calculate the aerodynamic derivatives for each channel, specifically: establish a mathematical model describing the forced harmonic oscillations according to the channels, developing an optimal program to minimize the cost function and estimate parameters.

Abstract: The present disclosure relates to semiconductor structures and, more particularly, to a vertical memory devices and methods of manufacture. The structure includes: a first bit cell with a first top electrode; a second bit cell with a second top electrode; and a common bottom electrode for both the first bit cell and the second bit cell.

Abstract: Pyrazole derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor.